Twist Bioscience Corp

NASDAQ:TWSTUnited States

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.

Contact Information

Headquarters

681 Gateway Blvd.SOUTH SAN FRANCISCO, CA, United States 94080

Phone

408-410-0105

Fax

302-531-3150

Executives

Chairman of the Board, Chief Executive Officer

Emily Leproust

President, Chief Operating Officer

Patrick Finn

Chief Financial Officer

Adam Laponis

Senior Vice President, General Counsel, Secretary and Chief Ethics and Compliance Officer

Dennis Cho

Senior Vice President - Advanced Development, General Manager of Data Storage and Director

William Banyai